Non small cell lung cancer secondary prevention: Difference between revisions

Jump to navigation Jump to search
(Mahshid)
No edit summary
 
Line 4: Line 4:


==Overview==
==Overview==
The secondary prevention of non-small cell lung cancer is based on the stage of non-small cell lung cancer at diagnosis. Secondary prevention include chest CT imaging along with periodic evaluation of alert signs in second-hand smokers or active smokers.<ref name="pmid10824565">{{cite journal |vauthors=Tominaga S |title=[Prevention of lung cancer--primary and secondary prevention] |language=Japanese |journal=Nippon Rinsho |volume=58 |issue=5 |pages=1149–52 |year=2000 |pmid=10824565 |doi= |url=}}</ref>
The secondary prevention of non-small cell lung cancer is based on the stage of non-small cell lung cancer at diagnosis. Secondary prevention includes chest CT imaging along with a periodic evaluation of alert signs in second-hand smokers or active smokers.


==Secondary Prevention==
==Secondary Prevention==
*Measures for secondary prevention for non-small cell lung cancer depends on the stage of non-small cell lung cancer at diagnosis.
Measures for secondary prevention for non-small cell lung cancer depends on the stage of non-small cell lung cancer at diagnosis.<ref name="pmid10824565">{{cite journal |vauthors=Tominaga S |title=[Prevention of lung cancer--primary and secondary prevention] |language=Japanese |journal=Nippon Rinsho |volume=58 |issue=5 |pages=1149–52 |year=2000 |pmid=10824565 |doi= |url=}}</ref><ref name="NCI">National Cancer Institute: PDQ® Lung Cancer Prevention. Bethesda, MD: National Cancer Institute. Date last modified 02/16/2016. Available at: http://www.cancer.gov/types/lung/hp/lung-prevention-pdq. Accessed </ref><ref name="pmid21263260">{{cite journal |vauthors=Van't Westeinde SC, van Klaveren RJ |title=Screening and early detection of lung cancer |journal=Cancer J |volume=17 |issue=1 |pages=3–10 |year=2011 |pmid=21263260 |doi=10.1097/PPO.0b013e3182099319 |url=}}</ref>
*The National Comprehensive Cancer Network (NCCN) recommends the following: <ref name="NCI">National Cancer Institute: PDQ® Lung Cancer Prevention. Bethesda, MD: National Cancer Institute. Date last modified 02/16/2016. Available at: http://www.cancer.gov/types/lung/hp/lung-prevention-pdq. Accessed </ref><ref name="pmid21263260">{{cite journal |vauthors=Van't Westeinde SC, van Klaveren RJ |title=Screening and early detection of lung cancer |journal=Cancer J |volume=17 |issue=1 |pages=3–10 |year=2011 |pmid=21263260 |doi=10.1097/PPO.0b013e3182099319 |url=}}</ref>
*The National Comprehensive Cancer Network (NCCN) recommends the following:
*The standard screening modality for early detection that has been shown substantial benefits is low-dose helical computed tomography (CT) scanning
**Low-dose helical computed tomography (CT) scanning is the standard screening modality for early detection.
*Annual screening (patients with high-risk), early detection is discontinued if patients have been 15 years without smoking.
**Annual screening (patients with high-risk), early detection is discontinued if patients have been 15 years without smoking.


==References==
==References==

Latest revision as of 21:00, 23 February 2018

Non Small Cell Lung Cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Non Small Cell Lung Cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT Scan

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Management Approach

Stage I
Stage II
Stage III
Stage IV
Metastatic Cancer

Medical Therapy

Chemotherapy
Radiation Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Non small cell lung cancer secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Non small cell lung cancer secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Non small cell lung cancer secondary prevention

CDC on Non small cell lung cancer secondary prevention

Non small cell lung cancer secondary prevention in the news

Blogs on Non small cell lung cancer secondary prevention

Directions to Hospitals Treating Non small cell carcinoma of the lung

Risk calculators and risk factors for Non small cell lung cancer secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

The secondary prevention of non-small cell lung cancer is based on the stage of non-small cell lung cancer at diagnosis. Secondary prevention includes chest CT imaging along with a periodic evaluation of alert signs in second-hand smokers or active smokers.

Secondary Prevention

Measures for secondary prevention for non-small cell lung cancer depends on the stage of non-small cell lung cancer at diagnosis.[1][2][3]

  • The National Comprehensive Cancer Network (NCCN) recommends the following:
    • Low-dose helical computed tomography (CT) scanning is the standard screening modality for early detection.
    • Annual screening (patients with high-risk), early detection is discontinued if patients have been 15 years without smoking.

References

  1. Tominaga S (2000). "[Prevention of lung cancer--primary and secondary prevention]". Nippon Rinsho (in Japanese). 58 (5): 1149–52. PMID 10824565.
  2. National Cancer Institute: PDQ® Lung Cancer Prevention. Bethesda, MD: National Cancer Institute. Date last modified 02/16/2016. Available at: http://www.cancer.gov/types/lung/hp/lung-prevention-pdq. Accessed
  3. Van't Westeinde SC, van Klaveren RJ (2011). "Screening and early detection of lung cancer". Cancer J. 17 (1): 3–10. doi:10.1097/PPO.0b013e3182099319. PMID 21263260.


Template:WikiDoc Sources